Tidal Investments’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
Tidal Investments's HAE Position: Q2 2026 in Review
Tidal Investments increased its Haemonetics (HAE) stake by 2.9% in Q2 2026, buying an estimated $33.2K and bringing the position to 18,357 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1566.
Tidal Investments first reported a position in HAE in Q1 2022 and has held it in 18 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Tidal Investments held 18,357 shares of Haemonetics worth $1.38M as of Q2 2026.
- Tidal Investments bought 517 Haemonetics shares in Q2 2026, an estimated $33.2K.
- Haemonetics made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1566 holding.
- Tidal Investments first reported a position in Haemonetics in Q1 2022 and has held it in 18 quarters since.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.